FDA plans upcoming adcomms for OTC contraceptive, epinephrine nasal spray, Intarcia's last shot
The FDA has scheduled or planned for three advisory committee meetings in May: one for an over-the-counter birth control pill, one for a nasal spray …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
